Trump Moves to Restrict Mifepristone Access and Defund Title X Clinics

The Trump administration directed the FDA to revisit mifepristone's approval and signaled it would halt Title X family planning funding to clinics that provide or refer for abortions. The moves — coming within days of inauguration — targeted the two largest pillars of federally supported reproductive healthcare. Reproductive rights advocates warned the actions would eliminate abortion medication access in states where it remained legal and shutter clinics serving low-income patients.